Imperva to Present at Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/26/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
- Needham Starts NeoVolta (NEOV) at Buy
- TD Cowen: 'Sober View Suggests Structural Alcohol Risks Are Overblown'
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
Oppenheimer Raises Price Target on Imperva (IMPV) to $75 Ahead of 2Q15 Results
August 5, 2015 7:01 AM EDTOppenheimer reiterated an Outperform rating on Imperva (NYSE: IMPV), and raised the price target to $75.00 (from $58.00), ahead of 2Q15 results. Analyst Shaul Eyal believes IMPV saw solid demand across all product and geographic regions. Oppenheimer raised revenue/EPS estimates to $48.7M/($0.22) from $48.2M/($0.22), going above... More
